Protagenic Therapeutics, Inc.\new License Costs (Deprecated 2018-01-31)
Protagenic Therapeutics, Inc.\new (PTIX) reported License Costs (Deprecated 2018-01-31) of $2.00 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LicenseCosts · last filed 2011-11-14
- Protagenic Therapeutics, Inc.\new license costs (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $2.00M, a 9.07% increase year-over-year.
- Protagenic Therapeutics, Inc.\new license costs (deprecated 2018-01-31) for the quarter ending 2011-06-30 was $2.30M, a 18.09% increase year-over-year.
- Protagenic Therapeutics, Inc.\new license costs (deprecated 2018-01-31) for the quarter ending 2010-09-30 was $1.83M.
- Protagenic Therapeutics, Inc.\new license costs (deprecated 2018-01-31) for the quarter ending 2010-06-30 was $1.95M.
| Period end | License Costs (Deprecated 2018-01-31) 3 month | License Costs (Deprecated 2018-01-31) 6 month | License Costs (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2011-09-30 | $2.00M 10-Q · filed 2011-11-14 | $4.29M derived: sum of 2 quarters · filed 2011-11-14 | $6.21M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $2.30M 10-Q/A · filed 2011-09-07 | $4.21M 10-Q/A · filed 2011-09-07 | |
| 2010-09-30 | $1.83M 10-Q · filed 2011-11-14 | $3.78M derived: sum of 2 quarters · filed 2011-11-14 | $5.69M 10-Q · filed 2011-11-14 |
| 2010-06-30 | $1.95M 10-Q/A · filed 2011-09-07 | $3.86M 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |